Pelvic floor and continence procedures economics

Pelvic floor procedures have unique reimbursement. Here’s the rate data and practice considerations.

As colorectal surgeons, we manage conditions that profoundly impact quality of life. The procedures we perform, from sacral neuromodulation to sphincteroplasty, require a high degree of specialization. This specialization is reflected in the procedural economics, but understanding the nuances of reimbursement is only half the battle. Maximizing practice revenue is the first step; structuring your financial life to keep and grow that income is the critical second step. For more foundational resources on the specialty, the colorectal surgery hub is a good starting point. This article, however, focuses on the money: both earning it from pelvic floor procedures and structuring your practice and personal finances to build lasting wealth.

Procedural Economics and Site of Service

The financial viability of offering advanced pelvic floor and continence procedures hinges on understanding reimbursement dynamics, which are heavily influenced by the site of service. Procedures like sacral neuromodulation (SNM) or percutaneous tibial nerve stimulation (PTNS) have different facility and professional fee components depending on whether they are performed in a hospital outpatient department (HOPD), an ambulatory surgery center (ASC), or an office setting.

For example, SNM (CPT 64561 for lead placement, 64581 for generator implantation) has a substantial facility fee component, making it a strong candidate for an ASC. The reimbursement can be significantly higher in an ASC that you own compared to just collecting a professional fee in a hospital setting. This is where the real economic leverage lies. To build a successful program, you need to model this out accurately. You can’t rely on anecdotal data from colleagues in different states or health systems. Payer contracts vary wildly, and what’s profitable for one group might be a loss-leader for another.

Building a pro forma requires granular data on your specific market’s commercial payer rates. This is where tools designed for this exact purpose become invaluable. Using CenterIQ rate intelligence, for instance, allows a practice to benchmark its rates against local competitors and model the financial impact of shifting procedures to an ASC. It helps answer the critical question: “If we build this service line in our own ASC, what is the actual ROI based on our dominant payers?” Without this data, you’re flying blind. Most of us learned this the hard way—by realizing a year into a new service line that the payer mix and contracted rates didn’t support the initial investment in equipment and staff.

ASC Ownership and K-1 Tax Structuring

Once you’ve used rate data to justify building or buying into an ASC, your income profile changes. You’re no longer just a W-2 employee or a partner drawing from a professional services entity. You’re now a business owner receiving partnership income, which typically flows to you via a Schedule K-1. This is a fundamental shift in your financial DNA.

Here’s how it works: The ASC, structured as a partnership or LLC taxed as a partnership, doesn’t pay income tax itself. Instead, it “passes through” the profits and losses to the partners. Your K-1 reports your share of this income. The key strategic question is whether your participation is “active” or “passive” under IRS §469 passive activity rules. For most surgeon-owners who are materially involved in the ASC’s operations, the income is active. This is crucial because if the ASC were to have a loss (especially in early years due to startup costs or accelerated depreciation), active participation allows you to deduct that loss against your other active income, like your surgical professional fees.

The trap many fall into is a poorly structured buy-in. If you finance your buy-in, your “at-risk” amount may limit the losses you can deduct. Furthermore, the interplay between your “reasonable compensation” from your surgical practice and the K-1 distributions from the ASC is a core tax planning conversation. The goal is to optimize this split for tax efficiency, which requires a CPA who understands the nuances of physician-owned ancillary services.

Leveraging Medical Real Estate via a Separate LLC

The most sophisticated surgical groups take the ASC model one step further: they own the building. This strategy, often called a “leaseback,” is one of the most powerful wealth-building tools available to physicians.

The structure is straightforward:
1. You and your partners form a separate LLC, completely distinct from your medical practice and your ASC entity.
2. This real estate LLC acquires the commercial property where your practice and/or ASC operates.
3. The real estate LLC then leases the property back to the medical practice/ASC at a fair market rate.

This creates three major financial benefits. First, the medical practice pays rent to your real estate LLC. This rent is a deductible business expense for the practice, reducing its taxable income. Second, the real estate LLC receives this rental income. Third, and most importantly, the real estate LLC gets to depreciate the building. Through a strategy called cost segregation, an engineering study can be performed to accelerate depreciation on components of the building (e.g., electrical, plumbing, fixtures), creating large paper losses in the early years of ownership.

Here’s the critical move: If your spouse can qualify for Real Estate Professional Status (REPS), those “paper losses” from depreciation can be used to offset your active surgical income. To qualify for REPS, your spouse must spend more than 750 hours per year and more than 50% of their total working time on real estate activities, all documented with a contemporaneous time log. This isn’t a loophole; it’s a congressionally approved strategy (under §469(c)(7)) designed for real estate professionals, and with careful planning, a surgeon’s spouse can meet the criteria. The trap is shoddy record-keeping. The IRS frequently audits REPS claims, and without a detailed, contemporaneous log, the deduction will be disallowed.

Stacking a Cash Balance Plan for Massive Tax Deferral

For a partner-track colorectal surgeon in their peak earning years (40s and 50s), a 401(k) is just the beginning. The single most powerful retirement savings and tax-deduction tool is a cash balance plan, which is a type of defined benefit pension plan.

Think of it as a supercharged, tax-deferred savings vehicle layered on top of your 401(k)/profit-sharing plan. While your 401(k) has a defined *contribution* limit (e.g., $76,500 in 2026 for the employee/employer total), a cash balance plan has a defined *benefit* at retirement. An actuary calculates the annual contribution needed to fund that future benefit, and for high-earning surgeons in their 50s, that annual contribution can easily be $200,000, $300,000, or even more.

This entire contribution is a tax-deductible expense for your practice. For a surgeon in the highest federal and state tax brackets, a $250,000 contribution to a cash balance plan could translate into over $100,000 in immediate, direct tax savings for that year. The funds grow tax-deferred, just like in a 401(k).

The planning trap here is inflexibility. Unlike a 401(k) where profit sharing can be discretionary, a cash balance plan has mandatory funding requirements. Once you establish the plan, the practice is obligated to make the actuarially determined contributions each year. If the practice has a down year, the funding is still due. This makes it a fantastic tool for stable, high-income practices but requires careful consideration of future income consistency before implementation.

The 199A QBI Deduction: Why Most Surgeons Don’t Qualify

When the Tax Cuts and Jobs Act of 2017 was passed, the Section 199A Qualified Business Income (QBI) deduction was a major headline. It allows owners of pass-through businesses (like partnerships and S-corps) to deduct up to 20% of their business income. However, Congress wrote a specific exclusion that directly impacts us.

The practice of medicine is defined as a “Specified Service Trade or Business” (SSTB). For SSTBs, the 199A deduction is phased out and ultimately eliminated for high earners. For the 2026 tax year, that phase-out range is projected to be around $394,000 of taxable income for single filers and $787,000 for those married filing jointly.

Let’s be direct: a successful, partner-track colorectal surgeon will almost certainly have income well above these thresholds. This means the 20% QBI deduction is off the table for your surgical practice income. It’s a warning, not a defeat. It simply means you cannot rely on this general business deduction and must instead focus on the more advanced, targeted strategies we’ve discussed: ASC ownership, real estate, and cash balance plans. The trap is wasting time and energy with a financial advisor who doesn’t understand this limitation and tries to contort your practice structure to chase a deduction you’ll never qualify for. Your planning efforts are better spent elsewhere.

Ultimately, building a financially successful career in colorectal surgery involves more than clinical excellence. It requires a CEO mindset—optimizing practice revenue by understanding procedural economics and then deploying sophisticated, entity-level strategies to maximize tax efficiency and build durable, long-term wealth.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 21, 2026